Curaleaf Launches Hostile Tender Offer for Aurora Cannabis
Curaleaf Holdings has launched a hostile tender offer to acquire Aurora Cannabis at $4 per share, representing a 45% premium. The bid includes both cash and stock components—0.3463 shares of Curaleaf plus $0.75 in cash for each Aurora share—and aims to create an international cannabis footprint across 17 countries by combining Curaleaf’s strong domestic revenue with Aurora's low-leverage balance sheet and European export network. The move signals a shift toward consolidation within the cannabis industry as regulatory barriers ease, particularly in North America and Europe. Shareholder tensions have escalated after private merger talks failed, prompting Curaleaf to file for an order halting Aurora’s at-the-market equity distribution facility, which it claims is being used defensively by management. Curaleaf's financial strength—$1.27 billion annual revenue with a debt-to-equity ratio of 1.06—is contrasted against Aurora Cannabis’ stronger liquidity position (debt-to-equity: 0.03; current ratio: 5.36). The tender offer is set to expire on December 1, 2026.
Topics: acquisition cannabis industry consolidation corporate strategy